Source: JAMA (Journal of the American Medical Association), August 12, 2009 issue
Aspirin (acetylsalicylic acid) appears to improve the survival rates of patients with non-metastatic (has not spread) colorectal cancer. The 5-year survival rate for patients regularly taking aspirin was 88% vs. 83% for non-aspirin consuming patients. 10-year survival rates were 74% vs. 69% respectively.
Aspirin is derived from the bark and leaves of the willow tree and is believed to have been utilized by the “father of medicine” himself, Hippocrates, between 460 B.C. and 377 B.C. Even at that time, the powder derivative was used to treat, headaches, pain and fever.
By approximately 1829, various independent German, Italian and French scientists identified and refined the compound salicin, which is identified as the pain reliever. Salicin was buffered over time to prevent destruction of stomach by the harsh acid. Aspirin compounds can actually be used to make plastic explosives. (Do not try this at home).
Whether aspirin and similar drugs can be used to prevent cancer in the future is currently being explored. As always, ask your doctor before taking aspirin.
posted by David Marc Schwadron, Esq.